Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ma Qin granules for postinfectious cough and cough variant asthma
CTR20190667Phase 2Active
- Sponsor
- Sichuan Academy of Chinese Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Maqin Granules in postinfectious cough, cough variant asthma (CVA), sponsored by Sichuan Academy of Chinese Medical Sciences. Started Apr 2019; status: active.
02
Drugs
Maqin Granules
03
Conditions
postinfectious coughcough variant asthma (CVA)
Beyond the preview
Go deeper on CTR20190667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190667.